Kyntra Bio, Inc. KYNB
1.95 USD -0.10 (-5.01%)
Regular-session close
1.89 -0.06 -3.25%
After hours · Nov 18, 4:00 PM ET
1.83 Day range 2.19
1.83 52-week range 10.47
- YTD
- -77.79%
- 1 year
- -77.33%
Benzinga news
benzinga.com Lake Street Maintains Buy on Kyntra Bio, Lowers Price Target to $8 Lake Street analyst Daniel Brims maintains Kyntra Bio (NASDAQ:KYNB) with a Buy and lowers the price target from $41 to $8.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release,…benzinga.com Oppenheimer Maintains Outperform on Kyntra Bio, Lowers Price Target to $30 Oppenheimer analyst Jay Olson maintains Kyntra Bio (NASDAQ:KYNB) with a Outperform and lowers the price target from $35 to $30.
benzinga.com HC Wainwright & Co. Maintains Buy on Kyntra Bio, Lowers Price Target to $18 HC Wainwright & Co. analyst Matthew Keller maintains Kyntra Bio (NASDAQ:KYNB) with a Buy and lowers the price target from $43 to $18.
benzinga.com Update: Kyntra Bio Q3 Adj. EPS $(3.42) Beats $(3.55) Estimate, Sales $1.762M Miss $1.766M Estimate Kyntra Bio (NASDAQ:KYNB) reported quarterly losses of $(3.42) per share which beat the analyst consensus estimate of $(3.55) by 3.66 percent. This is a 5.23 percent decrease over losses of $(3.25)…
